Home › Compare › MGUY vs MRK

MGUY vs MRK: Dividend Comparison 2026

MGUY yields 80000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGUY wins by $5.2077213163602945e+25M in total portfolio value
10 years
MGUY
MGUY
● Live price
80000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.2077213163602945e+25M
Annual income
$51,949,472,569,259,090,000,000,000,000,000.00
Full MGUY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MGUY vs MRK

📍 MGUY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGUYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGUY + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MGUY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGUY
Annual income on $10K today (after 15% tax)
$6,800,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,157,051,683,870,220,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MGUY beats the other by $44,157,051,683,870,220,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGUY + MRK for your $10,000?

MGUY: 50%MRK: 50%
100% MRK50/50100% MGUY
Portfolio after 10yr
$2.6038606581801473e+25M
Annual income
$25,974,736,284,629,546,000,000,000,000,000.00/yr
Blended yield
99.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MGUY
No analyst data
Altman Z
0.1
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGUY buys
0
MRK buys
0
No recent congressional trades found for MGUY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGUYMRK
Forward yield80000.00% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$5.2077213163602945e+25M$56.8K ✓
Annual income after 10y$51,949,472,569,259,090,000,000,000,000,000.00 ✓$9,798.13
Total dividends collected$5.206883835920424e+25M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MGUY vs MRK ($10,000, DRIP)

YearMGUY PortfolioMGUY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$8,010,700$8,000,000.00$11,206$366.19+$8.00M → MGUY
2$5,997,879,860$5,989,308,411.21$12,650$502.35+$5997.87M → MGUY
3$4,197,442,177,404$4,191,024,445,953.32$14,407$694.19+$4197442.16M → MGUY
4$2,745,581,773,359,261$2,741,090,510,229,439.00$16,585$967.82+$2745581773.34M → MGUY
5$1,678,610,723,842,080,800$1,675,672,951,344,586,500.00$19,342$1,363.89+$1678610723842.06M → MGUY
6$959,257,110,940,495,000,000$957,460,997,465,984,000,000.00$22,913$1,947.19+$959257110940495.00M → MGUY
7$512,381,218,321,420,100,000,000$511,354,813,212,713,760,000,000.00$27,662$2,823.89+$512381218321420096.00M → MGUY
8$255,816,465,068,545,120,000,000,000$255,268,217,164,941,240,000,000,000.00$34,159$4,173.35+$255816465068545114112.00M → MGUY
9$119,383,733,031,653,200,000,000,000,000$119,110,009,414,029,840,000,000,000,000.00$43,337$6,308.80+$1.193837330316532e+23M → MGUY
10$52,077,213,163,602,950,000,000,000,000,000$51,949,472,569,259,090,000,000,000,000,000.00$56,776$9,798.13+$5.2077213163602945e+25M → MGUY

MGUY vs MRK: Complete Analysis 2026

MGUY — Stock

Mogul Energy International, Inc. operates as an oil and gas exploration and development company. It operates the Stafford prospect located in Jackson County, Texas; the Alkek prospect situated in Goliad County, Texas; and the East Mathis prospect located in San Patricio County, Texas, as well as prospects across the Gulf Coast area of Texas. The company was founded in 2005 and is headquartered in Houston, Texas. On September 20, 2017, Mogul Energy International Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Southern District of Texas.

Full MGUY Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MGUY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGUY vs SCHDMGUY vs JEPIMGUY vs OMGUY vs KOMGUY vs MAINMGUY vs JNJMGUY vs ABBVMGUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.